La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PascalFrancis)

Index « FC03.fr.i » - entrée « Catécholamine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Catostomus commersoni < Catécholamine < Catégorie socioprofessionnelle  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000917 (2003) Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias [Canada] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni]Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
000971 (2003) Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications
000979 (2003) C. Warren Olanow [États-Unis] ; Christopher G. Goetz [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; A. Jon Stoessl [Canada] ; Vesna Sossi [Canada] ; Mitchell F. Brin [États-Unis] ; Kathleen M. Shannon [États-Unis] ; G. Michael Nauert [États-Unis] ; Daniel P. Perl [États-Unis] ; James Godbold [États-Unis] ; Thomas B. Freeman [États-Unis]A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's Disease
000B06 (2001) André Parent [Canada] ; Martine Cossette [Canada]Extrastriatal dopamine and Parkinson's disease
000B16 (2001) Oleh Hornykiewicz [Autriche]Dopamine and Parkinson's disease: A personal view of the past, the present, and the future
000B32 (2001) Raul De La Fuente-Fernandez [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease : PET evidence of increased dopamine turnover
000B49 (2000) Hong Y. Choi [Canada] ; Jin H. Song [Canada] ; Dong K. Park [Corée du Sud] ; Gregory M. Ross [Canada]The effects of ascorbic acid on dopamine-induced death of PC12 cells are dependent on exposure kinetics
000B50 (2000) James N. Oak [Canada] ; John Oldenhof [Canada] ; Hubert H. M. Van Tol [Canada]The dopamine D4 receptor : one decade of research
000C24 (1999) Juan Fernandez-Ruiz [États-Unis] ; Doris Doudet [Canada] ; Thomas G. Aigner [États-Unis]Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeys
000C32 (1999) Nicolaas Paul L. G. Verhoeff [Canada]Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders
000C62 (1999) R. Grondin [Canada] ; M. Goulet [Canada] ; M. Morissette [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958
000C90 (1998) A. Samii [Canada] ; S. R. Letwin [Canada] ; D. B. Calne [Canada]Prospects for new drug treatment in idiopathic parkinsonism
000D77 (1997) C. Thiffault [Canada] ; L. Lamarre-Theroux [Canada] ; R. Quirion [Canada] ; J. Poirier [Canada]L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse
000D91 (1997) C.-T. Lai [Canada] ; P. H. Yu [Canada]Dopamine- and L-β-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells : effects of oxidative stress and antioxidative factors
001007 (1992) S. J. Kish [Canada] ; K. Shannak ; A. Rajput ; J. H. N. Deck ; O. HornykiewiczAging produces a specific pattern of striatal dopamine loss : implications for the etiology of idopathic Parkinson's disease
001058 (1990) M. Guttman ; H. C. Fibiger ; A. Jakubovic ; D. B. CalneIntracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism
001097 (1989) C. Harnois ; G. Marcotte ; T. Di PaoloDifferent sensitivities to MPTP toxicity in primate nigrostriatal and retinal dopaminergic systems: electrophysiological and biochemical evidence
001131 (1988) T. L. Perry ; K. Jones ; S. Hansen ; R. A. Wall2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease
001171 (1986) T. Di Paolo ; P. Bedard ; M. Daigle ; R. BoucherLong-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys

List of associated Author.i

Nombre de
documents
Descripteur
3A. Jon Stoessl
3T. Di Paolo
2D. B. Calne
2Oleh Hornykiewicz
2Vesna Sossi
1A. Jakubovic
1A. Rajput
1A. Samii
1Alan L. Whone
1Ali H. Rajput
1André Parent
1Anthony E. Lang
1C. Harnois
1C. Thiffault
1C. Warren Olanow
1C.-T. Lai
1Chong S. Lee
1Christopher G. Goetz
1Claude Nahmias
1Daniel P. Perl
1David J. Brooks
1Donald B. Calne
1Dong K. Park
1Doris Doudet
1Frédéric Calon
1G. Marcotte
1G. Michael Nauert
1Gregory M. Ross
1H. C. Fibiger
1Hong Y. Choi
1Hubert H. M. Van Tol
1J. H. N. Deck
1J. Poirier
1James E. Holden
1James Godbold
1James N. Oak
1Jeffrey H. Kordower
1Jian-Qiang Lu
1Jin H. Song
1John Oldenhof
1Juan Fernandez-Ruiz
1K. Jones
1K. Shannak
1Kathleen M. Shannon
1L. Lamarre-Theroux
1M. Daigle
1M. Goulet
1M. Guttman
1M. Morissette
1Marc Morissette
1Margaret Davis
1Maria J. Ribeiro
1Martine Cossette
1Michael Schulzer
1Mitchell F. Brin
1Nicolaas Paul L. G. Verhoeff
1O. Hornykiewicz
1Olivier Rascol
1P. Bedard
1P. H. Yu
1P. J. Bedard
1Paul J. Bedard
1Philippe Remy
1R. A. Wall
1R. Boucher
1R. Grondin
1R. Quirion
1Raul De La Fuente-Fernandez
1Ray L. Watts
1Robert A. Hauser
1S. Hansen
1S. J. Kish
1S. R. Letwin
1Salma Jivan
1Sven Reske
1T. L. Perry
1Thomas B. Freeman
1Thomas G. Aigner
1Thomas J. Ruth
1Thérèse Di Paolo
1Werner Poewe

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i -k "Catécholamine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i  \
                -Sk "Catécholamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    FC03.fr.i
   |clé=    Catécholamine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022